Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-20-004869
Filing Date
2020-04-10
Accepted
2020-04-10 17:07:22
Documents
19
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A akorn10ka12312019.htm   iXBRL 10-K/A 1163071
2 EXHIBIT 10.50 exhibit10502019-execut.htm EX-10.50 14499
3 EXHIBIT 31.3 exhibit3132019-certificati.htm EX-31.3 4232
4 EXHIBIT 31.4 exhibit3142019-certificati.htm EX-31.4 4242
10 a2019salariedincentiveplan08.jpg GRAPHIC 138195
11 proxyimage.jpg GRAPHIC 197054
  Complete submission text file 0001628280-20-004869.txt   2361461

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20191231.xsd EX-101.SCH 4770
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20191231_cal.xml EX-101.CAL 671
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20191231_def.xml EX-101.DEF 1521
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20191231_lab.xml EX-101.LAB 39728
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20191231_pre.xml EX-101.PRE 20799
17 EXTRACTED XBRL INSTANCE DOCUMENT akorn10ka12312019_htm.xml XML 9289
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32360 | Film No.: 20787166
SIC: 2834 Pharmaceutical Preparations